{"url_path":"/sec/artl/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1621221/0001640334-26-000869-index.html","accession_number":"0001640334-26-000869","cik":"0001621221","ticker":"ARTL","issuer_name":"ARTELO BIOSCIENCES, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1621221/0001640334-26-000869-index.html","primary_entity_key":"0001621221","primary_entity_name":"ARTELO BIOSCIENCES, INC."},"word_count":53,"has_tables":true,"body_markdown":"**Item 5. Other Information**\n\n \n\n**Securities Trading Plans of Directors and Executive Officers**\n\n \n\nDuring our last fiscal quarter, none of our directors or officers, as defined in Rule 16a-1(f), adopted and/or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as defined in Regulation S-K Item 408.\n\n \n\n \n\n17\n\n*Table of Contents*"}